Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis

BACKGROUND: With the continuous development of cardiac interventional medicine, the incidence of contrast-induced nephropathy (CIN) is increasing every year, which is a serious threat to people's physical and mental health. Trimetazidine (TMZ) is a type of anti-ischemic drug developed in recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Ziliang, Lu, Haili, Su, Qiang, Guo, Wenqin, Dai, Weiran, Li, Hongqing, Yang, Huafeng, Li, Lang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340434/
https://www.ncbi.nlm.nih.gov/pubmed/28248861
http://dx.doi.org/10.1097/MD.0000000000006059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340434/
https://www.ncbi.nlm.nih.gov/pubmed/28248861
http://dx.doi.org/10.1097/MD.0000000000006059

Ejemplares similares